Search results for " type 2"

showing 10 items of 761 documents

Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials

2021

Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm con…

obesitymedicine.medical_specialtyMultiple SclerosisGlycemic ControlReviewType 2 diabeteslaw.inventionRandomized controlled trialWeight losslawDiabetes mellitusIntermittent fastingHumansMedicineTX341-641Intensive care medicineRandomized Controlled Trials as TopicGlycemicNutrition and Dieteticsexercisemedicine.diagnostic_testNutrition. Foods and food supplyintermittent fastingbusiness.industryFastingmedicine.diseaseObesityDiabetes Mellitus Type 2type 2 diabetesmedicine.symptombusinessLipid profileFood ScienceNutrients
researchProduct

Obesity and diabetes-Not only a simple link between two epidemics

2018

Summary Diabetes (DM) as well as obesity, due to their increasing incidence, were recognized as epidemic by the World Health Organization. Obesity is involved not only in the aetiopathogenesis of the most common worldwide type of DM—type 2 diabetes—but also in the development of its complications. There is also increasing scientific evidence regarding the role of obesity and overweight in type 1 diabetes. Weight gain may be considered as a complication of insulin treatment but also reveals significant pathophysiological impact on various stages of the disease. Another very important aspect related to DM as well as obesity is the microbiome, which is highly variable. The function of the gut …

obesitytype 1 diabetesEndocrinology Diabetes and Metabolismmicrobiome030209 endocrinology & metabolismReview ArticleType 2 diabetesDiseaseOverweightWeight GainBioinformatics03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistanceRisk Factorsinsulin resistanceDiabetes mellitusInternal MedicinemedicineHumans030212 general & internal medicineMicrobiomeEpidemicsReview ArticlesType 1 diabetesdiabetesbusiness.industrymedicine.diseaseObesityGastrointestinal MicrobiomeDiabetes Mellitus Type 1Diabetes Mellitus Type 2epidemiologytype 2 diabetesmedicine.symptombusinessDiabetes/Metabolism Research and Reviews
researchProduct

Should we measure routinely oxidized and small dense low-density lipoproteins in subjects with type 2 diabetes

2010

oxidized and small dense low-density lipoproteins type 2 diabetes
researchProduct

Ohjauksen kirjaaminen : tyypin 2 diabetespotilaiden omahoito ja osaaminen potilasasiakirjoissa

2017

The purpose of this study was to describe the contents of type 2 diabetes patient self-management counselling documentation, how counselling of self- management appeared in various content areas and how patients’ self- management competence developed during the counselling. The research data consisted of nurses’ documentations from type 2 diabetes patient self- management counselling situations (N = 60) in primary health care. The data was collected in 2014 from the period between the years 2005 and 2014. Data were analyzed using content analysis as well as a case study approach. The documentation of self-management counselling included entries from content areas on nutrition, exercise, wei…

perusterveydenhuoltoself-managementdiabetes mellitus type 2potilasasiakirjatkirjaaminendocumentationpotilaatterveysneuvontaosaaminenterveyskäyttäytyminenitsehoitoohjaus (neuvonta ja opastus)lääkehoitolifestyle counsellingohjausSisällönanalyysiaikuistyypin diabetesravitsemus
researchProduct

Conséquences d'un régime diabétogène enrichi en fructose sur la muqueuse olfactive : aspects anatomiques, fonctionnels et comportementaux

2015

The influence of metabolic status on olfactory processes has been thoroughly investigated over the last few years. Both nutritional status and hormones implicated in food metabolism can effectively modulate the olfactory system from the single neuron to the behavior. Thus, it seems likely that metabolic disorders such as type 2 diabetes (T2D) can induce olfactory dysfunctions. In fact T2D patients display poor olfactory performances however the effects of diabetes in itself (as well as underlying mechanisms) are still unknown. In this study, we investigated the modulation of olfaction in young adult male mice caused by a high-fructose diet (HFruD) inducing T2D in rodents. Animals displayed …

physiology[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]type 2 diabetesanimal behaviorComportement animal[SDV.AEN]Life Sciences [q-bio]/Food and NutritionDiabète de type 2Physiologieolfaction
researchProduct

Cukrzyca typu 2 i przewlekła choroba nerek jako czynniki rokownicze w ostrym zapaleniu trzustki

2019

Przeprowadzono analizę czynników rokowniczych ostrego zapalenia trzustki (OZT). Dokonano krytycznego przeglądu najważniejszych skali rokowniczych OZT: Apache II, Ransona, BISAP, Sofa, Marshalla. Wskazano na ich ograniczenia, ale i przydatność kliniczną we wczesnej stratyfikacji prognostycznej OZT. W diagnostyce różnicowej należy wyodrębniać etiologię alkoholową i żółciopochodną. Występująca przed zachorowaniem cukrzyca typu 2 i przewlekła choroba nerek znamiennie pogarszają przebieg OZT i powinny być włączone do skali rokowniczych. Wykazano, że obecność cukrzycy z poziomem HBA1C powyżej 6,5% wiąże się ze zwiększoną śmiertelnością wśród chorych na OZT i wydłuża się okres hospitalizacji o 5 d…

przewlekła choroba nerekacute pancreatitisdiabetes type 2cukrzyca typu 2ostre zapalenie trzustkiznaczenie rokowniczeseverity and prognostic scaleskale ciężkości i rokowaniachronic kidney diseaseprognostic significancePostępy Higieny i Medycyny Doświadczalnej
researchProduct

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study a…

2017

Background Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be poorly transferrable to clinical practice. Thus, evidence from studies using routinely accumulated clinical data are increasingly valued. Aims We herein describe rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes), a multicenter retrospective nationwide study conducted at 50 specialist outpatient clinics in Italy and promoted by the Italian Diabetes Society. Data synthesis The primary objective of the study is to describe the baseline clinical characteristics (particularly HbA1c) of pa…

randomized controlled trial; real-life; retrospective study; sodium glucose co-transporter-2 inhibitor; medicine (miscellaneous); endocrinology; diabetes and metabolism; nutrition and dietetics; cardiology and cardiovascular medicineBlood GlucoseTime FactorsGlucosideGlycated Hemoglobin ATime FactorMedicine (miscellaneous)Settore MED/13 - EndocrinologiaEndocrinologyGlucosidesSodium-Glucose Transporter 2Retrospective StudieDiabetes MellitusHumansHypoglycemic AgentsData MiningBenzhydryl CompoundsRandomized controlled trial; Real-life; Retrospective study; Sodium glucose co-transporter-2 inhibitor; Benzhydryl Compounds; Biomarkers; Blood Glucose; Data Mining; Diabetes Mellitus Type 2; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Italy; Research Design; Retrospective Studies; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Crowdsourcing; Evidence-Based Medicine; Medicine (miscellaneous); Endocrinology Diabetes and Metabolism; Nutrition and Dietetics; Cardiology and Cardiovascular MedicineSodium-Glucose Transporter 2 InhibitorsRetrospective StudiesGlycated HemoglobinBenzhydryl CompoundNutrition and DieteticsEvidence-Based MedicineHypoglycemic AgentSodium-Glucose Transporter 2 InhibitorRandomized controlled trial; Real-life; Retrospective study; Sodium glucose co-transporter-2 inhibitor; Benzhydryl Compounds; Biomarkers; Blood Glucose; Data Mining; Diabetes Mellitus Type 2; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Italy; Research Design; Retrospective Studies; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Crowdsourcing; Evidence-Based MedicineReal-lifeBiomarkerDiabetes and MetabolismRandomized controlled trial; Real-life; Retrospective study; Sodium glucose co-transporter-2 inhibitor; Benzhydryl Compounds; Biomarkers; Blood Glucose; Data Mining; Diabetes Mellitus Type 2; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Italy; Research Design; Retrospective Studies; Sodium-Glucose Transporter 2; Time Factors; Treatment Outcome; Crowdsourcing; Evidence-Based Medicine; Medicine (miscellaneous); Endocrinology Diabetes and Metabolism; Nutrition and Dietetics; Cardiology and Cardiovascular MedicineRetrospective studyTreatment OutcomeDiabetes Mellitus Type 2ItalyRandomized controlled trialResearch DesignSodium glucose co-transporter-2 inhibitorCrowdsourcingCardiology and Cardiovascular MedicineBiomarkersType 2Human
researchProduct

Influence du liraglutide (analogue du GLP-1) sur les caractéristiques hédoniques de la prise alimentaire et les performances gustatives, chez les pat…

2011

sensorialité gustativeobésité[SDV.AEN] Life Sciences [q-bio]/Food and Nutritiondiabète de type 2comportement alimentaire[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

The relationship between context, structure, and processes with outcomes of 6 regional diabetes networks in Europe

2018

BackgroundWhile health service provisioning for the chronic condition Type 2 Diabetes (T2D) often involves a network of organisations and professionals, most evidence on the relationships between the structures and processes of service provisioning and the outcomes considers single organisations or solo practitioners. Extending Donabedian's Structure-Process-Outcome (SPO) model, we investigate how differences in quality of life, effective coverage of diabetes, and service satisfaction are associated with differences in the structures, processes, and context of T2D services in six regions in Finland, Germany, Greece, Netherlands, Spain, and UK.MethodsData collection consisted of: a) systemat…

ta520MaleHealth Care ProvidersNursesEndocrinology0302 clinical medicineddc:150Medicine and Health SciencesMedical Personnel030212 general & internal medicineStatistical DataMultidisciplinary030503 health policy & servicesQRRegression analysisVariance (accounting)Type 2 DiabetesEuropeProfessionsPatient SatisfactionPhysical SciencesEngineering and TechnologyMedicineFemaleHealth Services Research0305 other medical sciencePsychologyStatistics (Mathematics)Research ArticleAdultEndocrine DisordersScienceEquipmentContext (language use)-Philosophische Fakultät und Fachbereich Theologie03 medical and health sciencesSERVQUALQuality of life (healthcare)Patient satisfactionSDG 3 - Good Health and Well-beingDiabetes MellitusHumansPrimary CareService qualityActuarial scienceData collectionCorrectionHealth CareDiabetes Mellitus Type 2Metabolic DisordersPeople and PlacesQuality of LifePopulation GroupingsMathematics
researchProduct

Elintapaohjauksen lähtökohtia korkeassa diabetesriskissä olevilla henkilöillä tyypin 2 diabeteksen ehkäisyn toimeenpanohankkeessa (D2D) : elintapaohj…

2012

terveyskasvatusperusterveydenhuoltoelintavatprimary health carepreventive health servicesterveysneuvontadiabetes mellitus type 2health behaviorterveyskäyttäytyminenhealth educationennaltaehkäisyhankkeetD2D-hankeaikuistyypin diabetes
researchProduct